AorTech International plc, together with its subsidiaries, focuses on the commercialization of its biomedical polymer technology, components, and medical devices in the United Kingdom. The company offers Elast-Eon, a bio stable polyurethane material used in long term implantation; and Elast-Eon Carbonate Silicone, a family of biomedical polymers for applications in cardiac pacing leads, orthopedics, and spinal discs, as well as in other applications where the device requires a high level of mechanical performance. It also provides Elast-Eon Reaction Injection Molding products for use in high-precision medical device components. In addition, the company licenses its technology; and offers support services to other medical device companies. AorTech International plc was incorporated in 1996 and is headquartered in Weybridge, the United Kingdom.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+44-1932-252123
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales£539,000.00
Profitability
Miscellaneous
Employees3
Next Earnings DateN/A
OptionableNot Optionable
AorTech International (LON:AOR) Frequently Asked Questions
What is AorTech International's stock symbol?
AorTech International trades on the London Stock Exchange (LON) under the ticker symbol "AOR."
Has AorTech International been receiving favorable news coverage?
Media headlines about AOR stock have trended extremely negative on Saturday, according to InfoTrie. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. AorTech International earned a news sentiment score of -4.6 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for AorTech International.
Who are some of AorTech International's key competitors?
Some companies that are related to AorTech International include Immunoprecise Antibodies (IPA), Actinium Pharmaceuticals (ATNM), OptiBiotix Health (OPTI), ReNeuron Group (RENE), Armata Pharmaceuticals (ARMP), Covalon Technologies (COV), Actinium Pharmaceuticals (ATNM), Emerald Health Therapeutics (EMH), AquaBounty Technologies (AQB), Kazia Therapeutics (KZA), 4d Pharma (DDDD), Oragenics (OGEN), Tiziana Life Sciences (TILS), Race Oncology (RAC) and Medicure (MPH).
What other stocks do shareholders of AorTech International own?
Who are AorTech International's key executives?
AorTech International's management team includes the folowing people:
- Mr. William Donald Brown, CEO, Exec. Chairman & Fin. Director (Age 55)
- Mr. John McKenna, Director of Clinical Marketing & Exec. Director (Age 66)
- Mr. Ajay Padsalgikar Ph.D., Chief Scientific Officer
- Mr. David J. C. Parsons, Company Sec.
How do I buy shares of AorTech International?
Shares of AOR and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is AorTech International's stock price today?
One share of AOR stock can currently be purchased for approximately GBX 77.50.
How big of a company is AorTech International?
What is AorTech International's official website?
How can I contact AorTech International?
AorTech International's mailing address is Level Two Springfield HSE, 23 Oatlands Drive, WEYBRIDGE, KT13 9LZ, United Kingdom. The company can be reached via phone at +44-1932-252123.
MarketBeat Community Rating for AorTech International (LON AOR)
MarketBeat's community ratings are surveys of what our community members think about AorTech International and other stocks. Vote "Outperform" if you believe AOR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AOR will underperform the S&P 500 over the long term. You may vote once every thirty days.
